UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030474 |
|---|---|
| Receipt number | R000033971 |
| Scientific Title | Early detection of pancreatic cancer with endoscopic ultrasound |
| Date of disclosure of the study information | 2018/11/14 |
| Last modified on | 2018/11/14 17:54:33 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Early detection of pancreatic cancer with endoscopic ultrasound
Acronym
Kinokuni Project
Scientific Title
Early detection of pancreatic cancer with endoscopic ultrasound
Scientific Title:Acronym
Kinokuni Project
Region
| Japan |
Condition
Condition
Pancreatic cancer
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Investigate whether the detection rate of early pancreatic cancer improves as a result of screening centering on ultrasonic endoscopy
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
the detection rate of early stage pancreatic cancers
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients who have a schedule to undergo endoscopic ultrasound
Key exclusion criteria
Patients who can not judge whether to participate in this study on their own, or who have a history of pancreatic cancers
Target sample size
2500
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Masayuki Kitano |
Organization
Wakayama Medical University
Division name
Department of Gastroenterology
Zip code
Address
Kimiidera 811-1, Wakayama City
TEL
073-445-3616
kitano@wakayama-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Masayuki Kitano |
Organization
Wakayama Medical University
Division name
Department of Gastroenterology
Zip code
Address
Kimiidera 811-1, Wakayama City
TEL
073-445-3616
Homepage URL
ninai@wakayama-med.ac.jp
Sponsor or person
Institute
Wakayama Medical University
Institute
Department
Personal name
Funding Source
Organization
Wkakayama Medical University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 11 | Month | 14 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2017 | Year | 05 | Month | 08 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 05 | Month | 08 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Based on the results of screening, we will calculate the rate of early stage pf pancreatic cancer.
Management information
Registered date
| 2017 | Year | 12 | Month | 19 | Day |
Last modified on
| 2018 | Year | 11 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033971
